Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBp 1,823.00
0.00 (0.00%)
Oct 30, 2025, 5:15 PM BST
Hikma Pharmaceuticals Employees
Hikma Pharmaceuticals had 9,500 employees as of December 31, 2024. The number of employees increased by 400 or 4.40% compared to the previous year.
Employees
9,500
Change (1Y)
400
Growth (1Y)
4.40%
Revenue / Employee
247.09K GBP
Profits / Employee
28.50K GBP
Market Cap
4.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9,500 | 400 | 4.40% |
| Dec 31, 2023 | 9,100 | 300 | 3.41% |
| Dec 31, 2022 | 8,800 | 100 | 1.15% |
| Dec 31, 2021 | 8,700 | 100 | 1.16% |
| Dec 31, 2020 | 8,600 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Hikma Pharmaceuticals News
- 4 weeks ago - FTSE 100 hits another high despite concerns over US government shutdown - Evening Standard
- 2 months ago - Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Pre Recorded Earnings Call Transcript - Seeking Alpha
- 2 months ago - Hikma Pharmaceuticals PLC 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call Transcript - Seeking Alpha
- 3 months ago - Hikma Pharmaceuticals tumbles after injectables margin outlook cut - Reuters
- 3 months ago - Hikma Pharmaceuticals: a quality compounder waiting for a catalyst - The Armchair Trader
- 4 months ago - Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US - PRNewsWire
- 4 months ago - Hikma Pharmaceuticals to invest $1B by 2030 to expand US manufacturing, R&D - Seeking Alpha